Search - tctmd.com

Displaying 741 - 760 of 868

Sort: Relevancy | Date

Presentation TCT 2012

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

Presenter: Dean Kereiakes

October 25, 2012

Presentation TCT 2012

SORT OUT IV 3-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Sirolimus-Eluting Stents

Presenter: Lisette Okkels Jensen

October 25, 2012

Presentation TCT 2012

LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents

Presenter: Patrick Serruys

October 25, 2012

Presentation TCT 2012

EXAMINATION 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Bare Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Manel Sabate

October 25, 2012

Presentation TCT 2012

Case 3: A Complex Bifurcation with Two or More Stents(Culotte Stenting)

Presenter: John Ormiston

October 25, 2012

Presentation TCT 2012

Case 2: A Complex Bifurcation with Two Stents (T-Stenting)

Presenter: David Rizik

October 25, 2012

Presentation TCT 2012

One or Two Stents: And How to Avoid Complications

Presenter: Kenneth Chin

October 24, 2012

Presentation TCT 2012

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Presenter: Julinda Mehilli

October 24, 2012

Presentation TCT 2012

Case Presentation 4: AUC and the Elephant in the Room: Unnecessary Stents

Presenter: Larry Dean

October 24, 2012

Presentation TCT 2012

Bioabsorbable Stent Components and Stents

Presenter: Shigeru Saito

October 24, 2012

Presentation TCT 2012

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

Presenter: John Ormiston

October 24, 2012

Presentation TCT 2012

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

Presenter: Hyeon-Cheol Gwon

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

News Conference News TCT 2012

Mesh-Covered Stent Shines in MASTER Trial

October 24, 2012

Presentation TCT 2012

MASTER: A Prospective, Randomized Trial of a PET Micronet Mesh-Covered Stent vs. Standard Stents in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Gregg Stone

October 24, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

Presentation TCT 2012

A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions

Presenter: Thomas Zeller

October 24, 2012

Presentation TCT 2012

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

Presenter: Josep Gomez-Lara

October 23, 2012

Advertisement

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

SORT OUT IV 3-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Sirolimus-Eluting Stents

LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents

EXAMINATION 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Bare Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction

Case 3: A Complex Bifurcation with Two or More Stents(Culotte Stenting)

Case 2: A Complex Bifurcation with Two Stents (T-Stenting)

One or Two Stents: And How to Avoid Complications

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Case Presentation 4: AUC and the Elephant in the Room: Unnecessary Stents

Bioabsorbable Stent Components and Stents

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

Mesh-Covered Stent Shines in MASTER Trial

MASTER: A Prospective, Randomized Trial of a PET Micronet Mesh-Covered Stent vs. Standard Stents in Patients with ST-Segment Elevation Myocardial Infarction

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content